title: The dominant negative β isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients.
abstract: Glucocorticoid receptor (GR) agonists increase erythropoiesis in vivo and in vitro. To clarify the effect of the dominant negative GRβ isoform (unable to bind STAT-5) on erythropoiesis, erythroblast (EB) expansion cultures of mononuclear cells from 18 healthy (nondiseased) donors (NDs) and 16 patients with polycythemia vera (PV) were studied. GRβ was expressed in all PV EBs but only in EBs from 1 ND. The A3669G polymorphism, which stabilizes GRβ mRNA, had greater frequency in PV (55%; n = 22; P = .0028) and myelofibrosis (35%; n = 20) patients than in NDs (9%; n = 22) or patients with essential thrombocythemia (6%; n = 15). Dexamethasone stimulation of ND cultures increased the number of immature EBs characterized by low GATA1 and β-globin expression, but PV cultures generated great numbers of immature EBs with low levels of GATA1 and β-globin irrespective of dexamethasone stimulation. In ND EBs, STAT-5 was not phosphorylated after dexamethasone and erythropoietin treatment and did not form transcriptionally active complexes with GRα, whereas in PV EBs, STAT-5 was constitutively phosphorylated, but the formation of GR/STAT-5 complexes was prevented by expression of GRβ. These data indicate that GRβ expression and the presence of A3669G likely contribute to development of erythrocytosis in PV and provide a potential target for identification of novel therapeutic agents.
authors.affiliation: The Tisch Cancer Institute and Myeloproliferative Disease Research Consortium, Mount Sinai School of Medicine, New York, NY, USA.
authors.forename: Lilian
authors.initials: L
authors.lastname: Varricchio
authors.forename: Elena
authors.initials: E
authors.lastname: Masselli
authors.forename: Elena
authors.initials: E
authors.lastname: Alfani
authors.forename: Angela
authors.initials: A
authors.lastname: Battistini
authors.forename: Giovanni
authors.initials: G
authors.lastname: Migliaccio
authors.forename: Alessandro Maria
authors.initials: AM
authors.lastname: Vannucchi
authors.forename: Wenyong
authors.initials: W
authors.lastname: Zhang
authors.forename: Damiano
authors.initials: D
authors.lastname: Rondelli
authors.forename: James
authors.initials: J
authors.lastname: Godbold
authors.forename: Barbara
authors.initials: B
authors.lastname: Ghinassi
authors.forename: Carolyn
authors.initials: C
authors.lastname: Whitsett
authors.forename: Ronald
authors.initials: R
authors.lastname: Hoffman
authors.forename: Anna Rita
authors.initials: AR
authors.lastname: Migliaccio
mesh_terms: D001483:Base Sequence; D018929:Cell Culture Techniques; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D003907:Dexamethasone / Q000494:pharmacology; D041905:Erythroid Cells / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology*; D015870:Gene Expression; D005799:Genes, Dominant / Q000235:genetics / Q000502:physiology; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D008954:Models, Biological; D008969:Molecular Sequence Data; D011086:Polycythemia / Q000235:genetics / Q000473:pathology; D011087:Polycythemia Vera / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D020641:Polymorphism, Single Nucleotide / Q000502:physiology; D020033:Protein Isoforms / Q000235:genetics; D011965:Receptors, Glucocorticoid / Q000235:genetics*
chemical_list: D005938:Glucocorticoids; D020033:Protein Isoforms; D011965:Receptors, Glucocorticoid; C121943:glucocorticoid receptor beta; D003907:Dexamethasone; C507924:JAK2 protein, human; D053614:Janus Kinase 2